Switching from Glargine to Degludec is not associated with an overt change in glucose control in a cohort of patients with type 1 diabetes: a CGM analysis

Acta Diabetol. 2018 Jun;55(6):637-639. doi: 10.1007/s00592-018-1121-3. Epub 2018 Mar 10.
No abstract available

Keywords: Continuous glucose monitoring; Degludec; Glargine; Hypoglycemia.